Table 2.
Vaccine | n. enrolled subjects* | n. of vaccinated subjects | % vaccinated (95% CI) | Apulian Vaccination Coverage 2012–14 birth cohorts | z | p |
---|---|---|---|---|---|---|
DTaP-IPV-HBV-Hib 1 dose | 159 | 156 | 98.1 (94.6–99.6) | 93.2 | 2.5 | 0.014 |
DTaP-IPV-HBV-Hib 2 doses | 159 | 145 | 91.2 (85.7–95.1) | 91.6 | 0.2 | 0.856 |
DTaP-IPV-HBV-Hib 3 doses | 158 | 138 | 87.3 (81.1–92.1) | 88.0 | 0.3 | 0.789 |
PCV 1 dose | 159 | 157 | 98.7 (95.5–99.8) | 92.5 | 3.0 | 0.003 |
PCV 2 doses | 159 | 144 | 90.6 (84.9–94.6) | 90.8 | 0.1 | 0.931 |
PCV 3 doses | 158 | 136 | 86.1 (79.7–91.1) | 86.8 | 0.3 | 0.795 |
MMR | 157 | 120 | 76.4 (69.0–82.8) | 78.7 | 0.7 | 0.482 |
Men C | 157 | 135 | 86.0 (79.6–91.0) | 84.4 | 0.6 | 0.581 |
Varicella | 157 | 127 | 80.9 (73.9–86.7) | 82.3 | 0.5 | 0.646 |
*for some subjects, complete immunization information were not available